The DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.
Adeno-Associated Viral Vectors as a Tool for Large Gene Delivery to the Retina
Open accessAbstract
Gene therapy using adeno-associated viral (AAV) vectors currently represents the most promising approach for the treatment of many inherited retinal diseases (IRDs), given AAV’s ability to efficiently deliver therapeutic genes to both photoreceptors and retinal pigment epithelium, and their excellent safety and efficacy profiles in humans. However, one of the main obstacles to widespread AAV application is their limited packaging capacity, which precludes their use from the treatment of IRDs which are caused by mutations in genes whose coding sequence exceeds 5 kb. Therefore, in recent years, considerable effort has been made to identify strategies to increase the transfer capacity of AAV vectors. This review will discuss these new developed strategies, highlighting the advancements as well as the limitations that the field has still to overcome to finally expand the applicability of AAV vectors to IRDs due to mutations in large genes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Adjustments, such as 200-300 bp of specific compatible overhangs, have resulted in normal concatemerization of independent gene cassettes such as the hybrid dual rAAV approach [214].”
From Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays (2020) · cites this paper as [214]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“An update on dual and triple rAAV vectors can be found in a recent paper by Trapani [214] who successfully applied a dual ABCA4 AAV vector system in Abca4 knockout mice [215,216].”
From Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays (2020) · cites this paper as [214]
The cited source says what the claim attributes to it.
In the citing paper
“In this context, localized subretinal delivery of therapeutic transgenes has demonstrated efficient photoreceptor engagement using AAV5,7,8 and 9 [126].”
From Circumventing the packaging limit of AAV-mediated gene replacement therapy for neurological disorders (2022) · cites this paper as [126]
In the citing paper
“The dual AAV vector system involves splitting the large transgene into two <5kb fragments that are packaged and co-delivered into the cell.”
From The Ocular Gene Delivery Landscape (2021) · cites this paper as [80]
In the citing paper
“The DNA fragments are then recombined into a complete functional transgene intracellularly either by homologous recombination or trans-splicing mechanisms [79,80,81].”
From The Ocular Gene Delivery Landscape (2021) · cites this paper as [80]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adeno-associated virus vector as a platform for gene therapy delivery
Wang, D., Tai, P. W. L., & Gao, G. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0012-9 · Cited by 2,444
Impairment of the Ubiquitin-Proteasome System by Protein Aggregation
Bence, N. F., Sampat, R. M., & Kopito, R. R. (2001) · Science · doi:10.1126/science.292.5521.1552 · Cited by 2,187
In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration
Suzuki, K., Tsunekawa, Y., Hernandez-Benitez, R., Wu, J., Zhu, J., Kim, E. J., Hatanaka, F., Yamamoto, M., Araoka, T., Li, Z., et al. (2016) · Nature · doi:10.1038/nature20565 · Cited by 1,150 · cited 1×
“First, in the retina, where homologous recombination occurs at low rates, genome editing tools for the precise correction of a mutation will most probably need to exploit alternative repair mechanisms such as non-homologous end joining used for homology-independent targeted integration [61].”
BackgroundEffect of genome size on AAV vector packaging
Wu, Z., Yang, H., & Colosi, P. (2010) · Molecular Therapy · doi:10.1038/mt.2009.255 · Cited by 1,029
Grieger, J. C., & Samulski, R. J. (2005) · Journal of Virology · doi:10.1128/jvi.79.15.9933-9944.2005 · Cited by 419
High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors
Petrs-Silva, H., Dinculescu, A., Li, Q., Min, S.-H., Chiodo, V., Pang, J.-J., Zhong, L., Zolotukhin, S., Srivastava, A., Lewin, A. S., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2008.269 · Cited by 398 · cited 1×
“Some studies have shown that use of capsid-engineered AAV variants with higher retinal transduction abilities, as tyrosine mutants capsids [39], led to higher levels of transgene expression from overlapping dual AAV vectors compared to naturally occurring AAV serotypes [20,33].”
Lai, Y., Thomas, G. D., Yue, Y., Yang, H. T., Li, D., Long, C., Judge, L., Bostick, B., Chamberlain, J. S., Terjung, R. L., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36612 · Cited by 389 · cited 1×
“, a minigene), has also been achieved with some success [58].”
BackgroundStargardt disease: clinical features, molecular genetics, animal models and therapeutic options
Tanna, P., Strauss, R. W., Fujinami, K., & Michaelides, M. (2017) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2016-308823 · Cited by 370 · cited 1×
“The efficacy of both oversized and dual AAV vectors in the retina has been evaluated in a number of studies using different reporter and therapeutic genes, such as ABCA4 and MYO7A mutated in Stargardt disease (STGD1) [31] and Usher syndrome type 1B (USH1B) [32], respectively.”
BackgroundIn Silico Reconstruction of the Viral Evolutionary Lineage Yields a Potent Gene Therapy Vector
Zinn, E., Pacouret, S., Khaychuk, V., Turunen, H. T., Carvalho, L. S., Andres-Mateos, E., Shah, S., Shelke, R., Maurer, A. C., Plovie, E., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.07.019 · Cited by 310 · cited 2×
“AAV5, AAV7, AAV8 and AAV9 serotypes have all been demonstrated to efficiently transduce photoreceptors [4,8].”
ResultTrans-splicing vectors expand the utility of adeno-associated virus for gene therapy
Yan, Z., Zhang, Y., Duan, D., & Engelhardt, J. F. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6716 · Cited by 305 · cited 2×
“The trans-splicing approach relies on the natural ability of AAV ITRs to concatemerize in order to reconstitute full-length genomes [22,25].”
Background
Cited by
Cremers, F. P. M., Lee, W., Collin, R. W. J., & Allikmets, R. (2020) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100861 · Cited by 315
“With dual AAV technology, cDNA fragments that exceed the cargo capacity of a single AAV can be split into two halves and each packaged into a separate AAV, with additional sequences that allow reconstitution of the complete cDNA once inside the target cell (Trapani, 2019).”
BackgroundGhosh, S., Brown, A. M., Jenkins, C., & Campbell, K. (2020) · Applied Biosafety · doi:10.1177/1535676019899502 · Cited by 218
Gene regulatory programmes of tissue regeneration
Goldman, J. A., & Poss, K. D. (2020) · Nature Reviews Genetics · doi:10.1038/s41576-020-0239-7 · Cited by 200
Usher syndrome: clinical features, molecular genetics and advancing therapeutics
Toms, M., Pagarkar, W., & Moosajee, M. (2020) · Therapeutic Advances in Ophthalmology · doi:10.1177/2515841420952194 · Cited by 133
Gene Therapy in Retinal Dystrophies
Ziccardi, L., Cordeddu, V., Gaddini, L., Matteucci, A., Parravano, M., Malchiodi-Albedi, F., & Varano, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225722 · Cited by 107
“Therefore, in recent years, considerable effort has been made to identify strategies to increase the transfer capacity of AAV vectors [62].”
Background
Metadata
- Authors
- Trapani, I.
- Affiliations
- Federico II University Hospital (IT)
- Corresponding author
- Trapani, Ivana
- ORCID
- Trapani, Ivana
- Venue
- Genes
- Publisher
- MDPI AG
- Published
- 2019-04-09
- Volume
- 10
- Issue
- 4
- Pages
- 287
- ISSN
- 2073-4425 (ISSN-L)
- PMC
- PMC6523333
- OpenAlex
- W2939601796
- Cited by
- 73
- References
- 62
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 9 · 2023: 8 · 2022: 10 · 2021: 14 · 2020: 16 · 2019: 4
- FWCI
- 6.61
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Genes (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Università degli Studi di Napoli Federico II (STAR programme)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- adeno-associated virus vectors, gene therapy, inherited retinal disease, photoreceptors, retinal pigment epithelium
- MeSH terms
- Dependovirus, Genetic Vectors, Humans, Photoreceptor Cells, Retina, Retinal Diseases, Genetic Therapy, Gene Transfer Techniques, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adeno-Associated Viral Vectors as a Tool for Large Gene Delivery to the Retina. https://app.cochat.ai/papers/10.3390/genes10040287
- The paper
- Trapani, I. (2019). Adeno-Associated Viral Vectors as a Tool for Large Gene Delivery to the Retina. Genes. https://doi.org/10.3390/genes10040287
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.